Key Takeaways
- A CPA-led EBITDA review that confirms add-backs and reconciles financials to bank deposits can help protect your valuation from later downward adjustments.
- Owners benefit from comparing doctor-to-doctor and DSO or private-equity options side-by-side, weighing cash at close, equity, post-close obligations, and timelines before choosing a transition route.
- A structured, NDA-protected marketing process that attracts multiple competing offers can turn a valuation estimate into an actual sale price and reduce single-buyer leverage.
- Due-diligence preparation, LOI negotiation, and purchase-agreement advocacy can be some of the main factors in avoiding re-trading and preserving value through closing.
- McLerran & Associates guides sellers through the entire post-valuation workflow; request a confidential discovery call to review your options and explore ways to protect your outcome.
1. Confirm Your Valuation and EBITDA Add-Backs
EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is the profitability metric that often drives dental practice valuations. Add-backs are discretionary, personal, or non-recurring expenses added back to net income to show the practice’s true economic earnings. Accurate EBITDA and add-backs create the foundation for every later negotiation.
A thorough post-valuation review should confirm the following:
- Owner compensation normalized to market-rate clinical pay
- Personal expenses run through the practice (auto, travel, insurance)
- One-time or non-recurring costs properly excluded
- Three to five years of tax returns, P&L statements, and production reports reconciled
- Collections verified against actual bank deposits, not just practice management software totals
- Accounts receivable aging reviewed for collectibility
These verification steps matter because industry data indicates that a significant portion of lower-middle-market deals face a downward purchase-price adjustment during due diligence, most often when add-backs are not defensible or collections are overstated. A weak or buyer-supplied valuation can quietly anchor what the owner ultimately receives. McLerran & Associates builds a CPA-led, diligence-grade EBITDA analysis before the practice goes to market, so the number can hold when buyers scrutinize it and the deal is less likely to be renegotiated down later.
2. Choose Between Doctor Buyer and DSO or Private Equity
Once you have a defensible valuation in hand, the next decision is which path to pursue: a doctor-to-doctor sale to a private buyer or an affiliation with a dental service organization or private-equity partner. These paths can differ significantly in timeline, structure, cash received at closing, and post-close obligations.
| Dimension | Doctor-to-Doctor | DSO / Private Equity |
|---|---|---|
| Typical timeline to close | 60–120 days from signed LOI | 90–180 days from signed LOI, corporate diligence often extends timelines |
| Seller work-back after close | Typically about 4–8 weeks, then exit | Minimum 5-year post-close employment term now commonly required |
| Cash at closing | Typically full price at close | Majority of consideration in cash at close, remainder in equity and earnouts |
| Equity component | None in most cases | Up to 40% of deal value as rollover equity |
Advisors who work only one path often cannot provide a genuine comparison. Because McLerran & Associates works doctor-to-doctor and dental service organization transactions in roughly equal measure, the firm can produce a true side-by-side valuation so owners decide with fuller information instead of a guess.
Compare both paths for your specific practice in a confidential consultation.
3. Set Your Asking Price and Build a Clear Prospectus
The confirmed valuation becomes the starting point for the asking price and the marketing materials, typically a Confidential Information Memorandum (CIM), sometimes called a Confidential Business Review (CBR). This document presents the practice’s financial performance, patient demographics, staff structure, lease terms, and growth profile to qualified buyers under a non-disclosure agreement.
Pricing discipline can influence outcomes. A practice with consistent revenue growth often receives stronger offers relative to asking price. Flat or declining revenue can result in lower offers. Over-pricing without a competitive process to support the number can invite re-trading, while under-pricing can permanently leave value on the table.
The prospectus should include:
- Three to five years of normalized financial statements and production reports
- Active patient count, recall compliance rate, and payor mix breakdown
- Staff roster, tenure, and compensation structure
- Lease terms, equipment inventory, and facility overview
- Growth opportunities and referral network summary
Confidential marketing materials are structured to advertise the practice without publicly identifying the seller, which can help protect staff relationships and patient goodwill. McLerran & Associates also builds a virtual data room, a comprehensive and organized repository of every document worth showcasing, before buyer outreach begins so the marketing process runs more smoothly.
4. Market Under NDA and Create Real Buyer Competition
A practice marketed to a single buyer usually has little competitive tension, and the buyer often sets the terms. A structured, auction-style process among multiple qualified buyers can convert a valuation estimate into a realized price.
Accepting a letter of intent from the first buyer who calls, without running a competitive process, can become one of the costliest decisions a dental practice owner makes. McLerran & Associates typically runs a 45–60-day bid process that generates around 10 offers per listing, with every buyer required to sign a non-disclosure agreement before receiving identifying information.
The competitive marketing process includes:
- Outreach to a vetted, pre-qualified pool of dental service organization and private-equity buyers
- Outreach to a large premier private-buyer pool for doctor-to-doctor paths
- Direct mail, geofencing, and study-club relationships for individual buyer identification
- Exclusion of poorly run or undercapitalized buyers from the process
- Parallel management presentations to short-listed buyers
The buyer universe for dental practices in 2026 includes roughly 130 PE-backed DSOs, which can reward sellers who create competition instead of negotiating with one party at a time.
5. Compare LOIs and Select Finalist Buyers
A Letter of Intent (LOI) is a non-binding preliminary document that outlines the proposed purchase price, deal structure, key conditions, and an exclusivity period, typically 60 to 120 days, during which the buyer conducts due diligence. The LOI is usually non-binding on most terms but binding on confidentiality and exclusivity. That structure often makes it the seller’s highest point of leverage before the practice is taken off the market.
Evaluating competing LOIs typically involves comparing:
- Total consideration and the split between cash at close, rollover equity, and earnouts
- Earnout structure, including whether targets appear achievable and whether near-miss provisions exist
- Equity level, such as joint-venture versus holding-company, and the dental service organization’s underlying financial health
- Post-close employment terms, compensation rate, and clinical autonomy provisions
- Non-compete radius, duration, and likely enforceability
- Buyer reputation, capitalization, and track record with prior sellers
The LOI phase often represents the seller’s maximum leverage point before due diligence begins. McLerran & Associates negotiates LOI terms on the owner’s behalf, then narrows the field to in-person meetings or headquarters visits with the top one to three finalists so the owner chooses from a position of strength rather than scarcity.
6. Navigate Due Diligence Without Price Chipping
Due diligence is the period after LOI signing when the buyer’s team, including financial analysts, attorneys, and often a Quality of Earnings (QoE) firm, verifies every material claim in the prospectus. A QoE review is an independent analysis of the practice’s reported earnings that aims to confirm that EBITDA is real, recurring, and not dependent on conditions that will not continue after the ownership change.
As noted earlier, many deals face downward price adjustments during diligence. Common triggers include:
- Add-backs that cannot be substantiated with documentation
- Collections overstated relative to actual bank deposits
- Seller production concentration above 65–70% of total practice revenue
- Fee schedule exposure, such as preferred insurance status that does not transfer to the buyer
- Recall compliance rates below what was represented
- Compliance gaps in HIPAA, OSHA, or employment documentation
McLerran & Associates performs diligence-grade work before the practice goes to market so the numbers are more defensible when the buyer’s QoE team arrives. During diligence, the firm actively defends the EBITDA it underwrote and reminds buyers that other vetted bidders remain available if they attempt to re-trade the agreed value.
7. Finalize the Purchase Agreement and Close
After due diligence, the parties move to the definitive agreement, either an Asset Purchase Agreement (APA) or a Stock Purchase Agreement. This contract is the legally binding document that governs the transaction. The APA details the assets transferred, representations and warranties, indemnification terms, and the conditions required for closing.
Key negotiation points at this stage often include:
- Working capital peg, which is the baseline level of cash and receivables required at closing and can significantly affect net proceeds
- Escrow holdbacks and indemnification caps
- Final employment agreement terms and compensation structure
- Earnout start date and measurement methodology
- Representations and warranties survival periods
McLerran & Associates coordinates with the owner’s dental-experienced attorney and CPA during this phase, serving as the quarterback who keeps all parties moving toward a timely close while working to avoid last-minute concessions that erode value.
8. Manage the Post-Close Transition for Stability
Closing marks a major milestone, yet the process continues after documents are signed. A poorly managed post-close transition can damage goodwill, trigger patient attrition, and, in earnout structures, directly reduce the seller’s future proceeds.
A 20–30% patient loss within 18 months after a dental practice acquisition can translate into a 20% or greater revenue decline, which can compound over time while fixed costs remain constant. Effective transition execution often includes:
- A coordinated announcement letter to patients, signed by both the outgoing and incoming dentist
- An in-person staff meeting to introduce the new owner before the public announcement
- A structured work-back period calibrated to the buyer type, typically 4–8 weeks for a doctor-to-doctor walk-away sale and a longer clinical commitment for DSO affiliations
- Clear communication about operational continuity, clinical philosophy, and staff retention
McLerran & Associates focuses on both price and fit throughout the process, helping select a buyer whose strategy, support model, and culture can protect the legacy, patients, and staff the seller is leaving behind.
45–90 Day Dental Practice Transition Timeline
The sequence below describes the core post-valuation workflow from market launch through closing.
Days 1–14: Valuation confirmed, EBITDA add-backs finalized, asking price set, and Confidential Information Memorandum built. Virtual data room assembled with three to five years of financials, production reports, lease, staff data, and compliance documentation.
Days 15–45: Confidential marketing launched under NDA to a vetted buyer pool. Indications of interest received, initial buyer conversations conducted, and management presentations scheduled with qualified candidates.
Days 45–60: Letters of Intent received and evaluated. Competing offers compared across price, structure, equity type, earnout terms, and post-close obligations. Top one to three finalists selected for in-person meetings or site visits.
Days 60–75: LOI negotiated and signed. Exclusivity period begins. Due diligence workstreams launched in parallel, including financial, operational, legal, clinical, and compliance reviews.
Days 75–90+: Quality of Earnings defense conducted. Definitive agreement drafted and negotiated. Working capital peg, holdbacks, and final employment terms confirmed. Closing conditions satisfied, funds wired, and ownership transferred.
Doctor-to-doctor transactions financed through SBA or conventional lending can complete the active post-valuation process in 60–120 days. DSO add-on acquisitions often require a longer active post-valuation process because of corporate diligence and approval procedures, and platform deals may extend further.
Frequently Asked Questions
How long does the dental practice sale process take after valuation?
The timeline varies by buyer type and practice complexity. For doctor-to-doctor transactions, the active process from market launch through closing can run 60 to 120 days, with the full process from valuation through closing often landing in the 6-to-9-month range. DSO and private-equity transactions typically require 3 to 6 months of active work after valuation because of institutional-grade due diligence and corporate approval procedures. Platform deals, where the practice becomes the foundation of a new DSO, can extend further. McLerran & Associates usually runs a 45–60-day competitive bid process that generates around 10 offers, which can compress the time to LOI while maintaining competitive tension.
What is a Letter of Intent, and why does it matter so much in a dental practice sale?
A Letter of Intent (LOI) is a preliminary, mostly non-binding document that outlines the proposed purchase price, deal structure, key conditions, and an exclusivity period, typically 60 to 120 days, during which the buyer conducts due diligence. It is binding on confidentiality and exclusivity, which means once it is signed, the practice is effectively off the market while the buyer investigates. This structure often makes the LOI the seller’s highest point of leverage, because terms negotiated before signing are usually easier to secure than after. McLerran & Associates negotiates LOI terms on the owner’s behalf, including earnout structure, equity type, post-close employment terms, and non-compete provisions, before the exclusivity clock starts.
What is re-trading, and how can a dental practice owner reduce the risk?
Re-trading occurs when a buyer uses findings from due diligence to demand a lower price or more favorable terms after the LOI has been signed and the practice has been taken off the market. It can be one of the most common and costly risks in dental practice sales. A primary prevention strategy involves diligence-grade preparation before going to market, including a CPA-led EBITDA analysis with every add-back documented, financials reconciled to actual bank deposits, compliance records organized, and a clean data room assembled before buyer outreach begins. When this homework is done up front, buyers have fewer surprises to exploit. McLerran & Associates builds this foundation before the practice is listed, then actively defends the agreed EBITDA when the buyer’s Quality of Earnings team conducts its review and reminds buyers that other vetted bidders remain available if they attempt to chip the deal.
How is a dental service organization deal different from a doctor-to-doctor sale in terms of what the seller actually receives?
The two paths can differ substantially in structure, timeline, and post-close obligations. A doctor-to-doctor sale typically delivers the full purchase price at closing, requires a short work-back period of about 4 to 8 weeks, and involves a relatively straightforward asset purchase agreement. A dental service organization or private-equity affiliation usually delivers most of the total consideration in cash at closing, with the remainder structured as rollover equity, meaning ownership in the dental service organization, and potentially an earnout tied to post-close performance targets. The equity component can represent 20 to 40% of the total deal value, so the seller is effectively investing in the dental service organization and may want to evaluate its financial health, management team, and private-equity backing carefully. Dental service organization deals also typically require a minimum multi-year post-close clinical commitment. As shown in the comparison table above, McLerran & Associates models both paths side-by-side, including multi-year, after-tax cash-flow projections, so owners can evaluate which path appears to align better with their goals.
Conclusion
The eight steps above, including valuation review, path selection, pricing and prospectus preparation, competitive marketing, LOI evaluation, due diligence defense, purchase agreement negotiation, and post-close transition, together describe a complete post-valuation workflow for a dental practice sale. Each step carries its own risks, and the outcome at each stage can shape what the owner ultimately walks away with.
Going it alone or relying on a weak valuation can invite re-trading, lower close rates, and value erosion at the moments when an experienced advocate may matter most. McLerran & Associates has guided owners through approximately 2,000 practice sales and more than $2 billion in closed transaction volume, achieving a transaction rate of roughly 85–90%, compared to an industry norm closer to 35–40%, and delivering higher valuations on average than owners often achieve selling on their own.
The firm works exclusively on the sell side and maintains the balanced buyer access described earlier, while building a diligence-grade foundation that can hold up when sophisticated buyers review the details.
